QAi Ki-67 Quant - Sectra Amplifier Marketplace

Description of use

QAi Ki-67 Quant executes AI analysis of ROIs (Region of Interest) to detect the presence of Ki-67 nuclei, classifying body tissues responding positively or negatively to the biomarker, and quantifying their relative ratios. It is a clinical-decision-support system designed to assist pathologists in the analysis of IHC slides for the detection of the cancer biomarker.

How is the application integrated?

Application can be launched from Sectra's pathology image window: Yes

Results will be shown in Sectra's pathology image window: Yes

Ask your Sectra representative which version of the Sectra PACS is compatible with the highlighted integration standards.

Contact us

Referring articles

The below are peer-reviewed articles that have been submitted by the AI vendor to serve as scientific validation of the application.

Other applications by this vendor

QAi Colon Dx

Research only | H&E

Clinical-decision-support system for the classification of body tissues as benign, inflamed, or dysplastic, and the detection of malignant areas to screen, diagnose, and report on colorectal cancers.

QAi Prostate Dx

Research only | H&E

Clinical-decision-support system for screening, diagnosing, and reporting on H&E-stained prostate core needle biopsy

Let’s talk

Are you interested in learning more? Please do not hesitate to get in touch with us at Sectra.

Contact us

The application content is provided by the respective AI vendors.